Company Summary

Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company was set up on Wednesday the 16th of June 1976. Their current partial address is Dublin, and the company status is Normal. The company's current directors have been the director of 1 other Irish company between them. Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company has 1 shareholder. This Irish company shares its Eircode with at least 193 other companies.

Company Name:Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company
Company Status:NORMAL
Company Address:6th Floor,
South Bank House,
Barrow Street Dublin 4,
Dublin 4, Dublin
Telephone:+353 (0)1 609 7100
Website:www.astrazeneca.com
Key Executive:Mr O'Reilly
Company Size:Log-In To View
Disclaimer Other Details
Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us.

Key Contact Profile

Mr O'Reilly is a Company Director of Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company since 2019

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
Form B1C - Annual Return General30/09/202304/10/2023Join Up
FINANCIAL STATEMENT30/09/202304/10/2023Join Up
OTHER DIRECTORSHIP LIST30/09/202304/10/2023Join Up
B10 CHANGE IN DIRECTORS/SECRETARY19/07/202320/07/2023Join Up
Form B1C - Annual Return General05/09/202220/09/2022Join Up
THIS COMPANY HAS 150 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company.

Company Status:Normal
Latest Credit Movement:
Date of Last Movement:06/10/2023
Latest Accounts Filed:04/10/2023
Report Based on Accounts:31/12/2022
Next Set of Accounts Due:30/09/2024
Overdue:No
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors & Owners

Satisfy due diligence requirements on Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company and Anti-Money Laundering checks (AML checks) on Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company

Directors details are available to logged in users.

Ownership Structure

Company Type:DAC - Designated Activity Company (Limited By Shares)
Number of Shareholders:1

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Astrazeneca Pharmaceuticals (Ireland) Designated Activity Company or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

You Can Make Smarter Decisions, and Automate them with StrategyOne

28/11/2023

We all could use more time in the day to focus on our value-adding tasks, but manual admin, data analysis and decision making takes time, and for good reason.

Read More »

The Individual Accountability Framework - What You Need to Know

01/11/2023

Earlier this year the Central Bank of Ireland (CBI) enacted the Individual Accountability Framework (IAF) with the aim of promoting an improved governance system and positive cultural change in Regulated Financial Service Providers (RFSPs).

Read More »

The Persistent Nature of Inflation Contributes to the Elevated Insolvency Rates

20/10/2023

Examining the third quarter of this year against last year presents a peculiar picture.

Read More »

12% Year-On-Year Start-up Increase in Q3

16/10/2023

A 12% year-on-year increase in the number of company start-ups was recorded for the third quarter of 2023, with 185 insolvencies recorded in Q3 this year.

Read More »